Literature DB >> 4341966

Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.

M E Carter, V H James.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4341966      PMCID: PMC1005948          DOI: 10.1136/ard.31.5.379

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  ALTERNATE-DAY STEROID THERAPY FOR NEPHROTIC CHILDREN.

Authors:  L F SOYKA; K M SAXENA
Journal:  JAMA       Date:  1965-04-19       Impact factor: 56.272

2.  Single daily dose corticosteroid treatment. Effect on adrenal function and therapeutic efficacy in various diseases.

Authors:  A B Myles; P A Bacon; J R Daly
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

3.  Effect of corticotrophin therapy on pituitary-adrenal function.

Authors:  M E Carter; V H James
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

4.  A semi-automated fluorimetric procedure for the determination of plasma corticosteroids.

Authors:  J Townsend; V H James
Journal:  Steroids       Date:  1968-04       Impact factor: 2.668

5.  Adrenocortical responsiveness after alternate-day corticosteroid therapy.

Authors:  G L Ackerman; C M Nolsn
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

6.  Adrenal function, growth, and insulin in patients treated with corticoids on alternate days.

Authors:  A Sadeghi-Nejad; B Senior
Journal:  Pediatrics       Date:  1969-02       Impact factor: 7.124

7.  Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen.

Authors:  L F Soyka
Journal:  Am J Dis Child       Date:  1967-06

8.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects.

Authors:  F C Greenwood; J Landon; T C Stamp
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

9.  Pituitary-adrenal responsiveness after coricosteroid therapy in children with nephrosis.

Authors:  D S Fleisher
Journal:  J Pediatr       Date:  1967-01       Impact factor: 4.406

  9 in total
  7 in total

1.  Absorption of enteric and non-enteric coated prednisolone tablets.

Authors:  B Hulme; V H James; R Rault
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

Authors:  P J Morrison; I D Bradbrook; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

3.  Conversion from daily to alternate daily corticosteroids in rheumatoid arthritis.

Authors:  M A Fitzcharles; J Halsey; H L Currey
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

Review 4.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

5.  Polymyalgia rheumatica. Abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations.

Authors:  W Esselinckx; S M Doherty; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

6.  Single daily dose corticosteroid treatment.

Authors:  A B Myles; L F Schiller; D Glass; J R Daly
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

7.  The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients.

Authors:  Genny Margarita Chaia-Semerena; María Eugenia Vargas-Camaño; Cesar Daniel Alonso-Bello; Jorge Javier Guillén-Toledo; Ricardo Leopoldo Guido-Bayardo; Fernando Lozano-Patiño; Mariano Daniel Temix-Delfín; María Isabel Castrejón-Vázquez
Journal:  Autoimmune Dis       Date:  2020-05-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.